These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 34551425)

  • 1. Efficient and targeted COVID-19 border testing via reinforcement learning.
    Bastani H; Drakopoulos K; Gupta V; Vlachogiannis I; Hadjichristodoulou C; Lagiou P; Magiorkinis G; Paraskevis D; Tsiodras S
    Nature; 2021 Nov; 599(7883):108-113. PubMed ID: 34551425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A methodology for estimating SARS-CoV-2 importation risk by air travel into Canada between July and November 2021.
    Milwid RM; Gabriele-Rivet V; Ogden NH; Turgeon P; Fazil A; London D; de Montigny S; Rees EE
    BMC Public Health; 2024 Apr; 24(1):1088. PubMed ID: 38641571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What effect might border screening have on preventing the importation of COVID-19 compared with other infections? A modelling study.
    Bays D; Bennett E; Finnie T
    Epidemiol Infect; 2021 Nov; 149():e238. PubMed ID: 34732268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies at points of entry to reduce importation risk of COVID-19 cases and reopen travel.
    Dickens BL; Koo JR; Lim JT; Sun H; Clapham HE; Wilder-Smith A; Cook AR
    J Travel Med; 2020 Dec; 27(8):. PubMed ID: 32841354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A SARS-CoV-2 Surveillance System in Sub-Saharan Africa: Modeling Study for Persistence and Transmission to Inform Policy.
    Post LA; Argaw ST; Jones C; Moss CB; Resnick D; Singh LN; Murphy RL; Achenbach CJ; White J; Issa TZ; Boctor MJ; Oehmke JF
    J Med Internet Res; 2020 Nov; 22(11):e24248. PubMed ID: 33211026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determining quarantine length and testing frequency for international border opening during the COVID-19 pandemic.
    Dickens BL; Koo JR; Lim JT; Park M; Sun H; Sun Y; Zeng Z; Quaye SED; Clapham HE; Wee HL; Cook AR
    J Travel Med; 2021 Oct; 28(7):. PubMed ID: 34104959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deep reinforcement learning approaches for global public health strategies for COVID-19 pandemic.
    Kwak GH; Ling L; Hui P
    PLoS One; 2021; 16(5):e0251550. PubMed ID: 33984043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rapid review of the effectiveness of screening practices at airports, land borders and ports to reduce the transmission of respiratory infectious diseases such as COVID-19.
    Chetty T; Daniels BB; Ngandu NK; Goga A
    S Afr Med J; 2020 Oct; 110(11):1105-1109. PubMed ID: 33403987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Universal testing for severe acute respiratory syndrome coronavirus 2 in 2 Philadelphia hospitals: carrier prevalence and symptom development over 2 weeks.
    Bender WR; Hirshberg A; Coutifaris P; Acker AL; Srinivas SK
    Am J Obstet Gynecol MFM; 2020 Nov; 2(4):100226. PubMed ID: 32954248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymptomatic and Presymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection Rates in a Multistate Sample of Skilled Nursing Facilities.
    White EM; Santostefano CM; Feifer RA; Kosar CM; Blackman C; Gravenstein S; Mor V
    JAMA Intern Med; 2020 Dec; 180(12):1709-1711. PubMed ID: 33074318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 infection among international travellers: a prospective analysis.
    Lunney M; Ronksley PE; Weaver RG; Barnieh L; Blue N; Avey MT; Rolland-Harris E; Khan FM; Pang JXQ; Rafferty E; Scory TD; Svenson LW; Rodin R; Tonelli M
    BMJ Open; 2021 Jun; 11(6):e050667. PubMed ID: 34168036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demographic, clinical, and epidemiologic characteristics of persons under investigation for Coronavirus Disease 2019-United States, January 17-February 29, 2020.
    McGovern OL; Stenger M; Oliver SE; Anderson TC; Isenhour C; Mauldin MR; Williams N; Griggs E; Bogere T; Edens C; Curns AT; Lively JY; Zhou Y; Xu S; Diaz MH; Waller JL; Clarke KR; Evans ME; Hesse EM; Morris SB; McClung RP; Cooley LA; Logan N; Boyd AT; Taylor AW; Bajema KL; Lindstrom S; Elkins CA; Jones C; Hall AJ; Graitcer S; Oster AM; Fry AM; Fischer M; Conklin L; Gokhale RH
    PLoS One; 2021; 16(4):e0249901. PubMed ID: 33857209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spread of a SARS-CoV-2 variant through Europe in the summer of 2020.
    Hodcroft EB; Zuber M; Nadeau S; Vaughan TG; Crawford KHD; Althaus CL; Reichmuth ML; Bowen JE; Walls AC; Corti D; Bloom JD; Veesler D; Mateo D; Hernando A; Comas I; González-Candelas F; ; Stadler T; Neher RA
    Nature; 2021 Jul; 595(7869):707-712. PubMed ID: 34098568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Greece used AI to curb COVID: what other nations can learn.
    Nature; 2021 Sep; 597(7877):447-448. PubMed ID: 34552260
    [No Abstract]   [Full Text] [Related]  

  • 16. Surveillance Metrics of SARS-CoV-2 Transmission in Central Asia: Longitudinal Trend Analysis.
    Post LA; Benishay ET; Moss CB; Murphy RL; Achenbach CJ; Ison MG; Resnick D; Singh LN; White J; Chaudhury AS; Boctor MJ; Welch SB; Oehmke JF
    J Med Internet Res; 2021 Feb; 23(2):e25799. PubMed ID: 33475513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymptomatic carriers of COVID-19 in a confined adult community population in Quebec: A cross-sectional study.
    Cloutier L; Merindol N; Pépin G; Marcoux-Huard C; Vasil PA; Houle C; Todkar S; Lehoux MC; Houle N; Germain H; Danylo A
    Am J Infect Control; 2021 Jan; 49(1):120-122. PubMed ID: 32835745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effectiveness of full and partial travel bans against COVID-19 spread in Australia for travellers from China during and after the epidemic peak in China.
    Costantino V; Heslop DJ; MacIntyre CR
    J Travel Med; 2020 Aug; 27(5):. PubMed ID: 32453411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lessons from the Lab: SARS-CoV-2 Detection Rate amongst the Vaccinated Travel Lane and Non-Vaccinated Travel Lane Travellers into Malaysia.
    Chuan BC; Zulkufli NS; Rajesvaran C; Yon R; Khee SL
    Malays J Med Sci; 2023 Apr; 30(2):153-160. PubMed ID: 37102055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The first laboratory-confirmed imported infections of SARS-CoV-2 in Sudan.
    Aljak ER; Eldigail M; Mahmoud I; Elhassan RM; Elduma A; Ibrahim AA; Ali Y; Weaver SC; Ahmed A
    Trans R Soc Trop Med Hyg; 2021 Jan; 115(1):103-109. PubMed ID: 33319246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.